LCN2 and Stroke: To assess whether LCN2 mAb targeted endogenous LCN2 that was induced after stroke, brain homogenates and blood sera of LCN2+/+ and LCN2−/− mice collected before and after tMCAo were analyzed by immunoprecipitation.